3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
3
Thoracic
1
Other neoplasm
1
Gynecologic
1
Breast
1
Conditions
Carcinoma, Ovarian Epithelial
5
Ovarian Neoplasms
4
Breast Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Sarcoma, Synovial
1
Sarcoma, Endometrial Stromal
1
Sarcoma, Alveolar Soft Part
1
Sarcoma
1
Rhabdomyosarcoma
1
Peritoneal Neoplasms
1
Pancreatic Neoplasms
1
Neurofibrosarcoma
1
Melanoma
1
Malignant mesenchymal tumor
1
Lung Neoplasms
1
Liver Neoplasms
1
Liposarcoma
1
Leiomyosarcoma
1
Histiocytoma, Malignant Fibrous
1
Hemangiosarcoma
1
Head and Neck Neoplasms
1
Fibrosarcoma
1
Fallopian Tube Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Desmoplastic Small Round Cell Tumor
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Interventions
pembrolizumab
5
Cyclophosphamide
4
Carboplatin
4
Filgrastim
3
fludarabine
2
Thiotepa
2
Temozolomide
2
Riluzole
2
Psychiatric Rehabilitation
2
Polymerase Chain Reaction
2
Peripheral Blood Stem Cell Transplantation
2
Immunohistochemistry
2
Drug Therapy
2
Counseling
2
Bupropion
2
vofatamab
1
utomilumab
1
trastuzumab deruxtecan
1
toripalimab
1
tasquinimod
1
sodium thiosulfate
1
sargramostim
1
saracatinib
1
poly ICLC
1
pertuzumab
1
liposomal doxorubicin
1
lenvatinib
1
ixabepilone
1
etoposide phosphate
1
durvalumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Liver Neoplasms
×
Mass Spectrometry
×
Gynecologic
×
Clear all
NCT00900094
2012-02-07
IRB 2000-294
University of Michigan Rogel Cancer Center
Completed
200 enrolled